Account

Sign in to access your account and subscription

LJN Newsletters

  • In a drug or medical device injury case, one of the defense's most potent arguments often is that the product in question underwent FDA approval. But when a device is approved for sale to the public through the FDA's 510(k) process, the rigorous safety and efficacy analysis required of new and unique medical devices has not been undertaken.

    December 01, 2017Janice G. Inman
  • The Presumption of Legitimacy

    In what is being hailed as a landmark decision, New York's Appellate Division, First Department, recently held that the presumption that a child born to a married couple is their legitimate offspring applies not only to biological children of both spouses, but also to children born through more modern means — even when the married parties are in a same-sex marriage.

    December 01, 2017Janice G. Inman
  • The author discusses how acronyms (and some initialisms) can help you become a better communicator.

    December 01, 2017John J. Buchanan
  • The authors discuss several steps to take in order to avoid the pitfalls that could accompany lengthy exposure vis-à-vis state false claims actions.

    December 01, 2017Jacqueline C. Wolff and Benjamin J. Wolfert
  • Failure to increase senior billing rates differentially, and thus to rebalance the source of margin from junior to senior lawyer time, will result in a calamitous decline in profitability. It can be avoided if firms start now to gradually change their billing rate structures.

    December 01, 2017Hugh A. Simons
  • Part One of a Two-Part Article

    When you take a catastrophic injury case involving paralysis, it is important to have a thorough understanding of the problems and pitfalls. In this two-part article, I will explore, from personal experience, the different types of future expenses the client can expect to incur.

    December 01, 2017Mitch Warnock